ArticleMedicine2026
The quality and reliability of short videos on acute myeloid leukemia on Bilibili and TikTok: A cross-sectional study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Alcohol-related health information on Chinese short-video platforms: a cross-sectional content analysis of Douyin and Bilibili.Scientific reports · 2026Article
- Quality and reliability of myelodysplastic syndromes-related health information on Chinese short-video platforms: a multi-platform cross-sectional analysis.Frontiers in digital health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute myeloid leukemia (AML) is a life-threatening hematological malignancy. With the rapid development of short video platforms, TikTok and Bilibili have become important sources of health information; however, the quality and reliability of AML-related content remain unclear. This study aims to evaluate the content, quality, and reliability of short AML videos on these platforms. The top 150 AML-related videos were collected from each platform using default ranking. Video quality was assessed using 3 validated instruments: the global quality score, modified DISCERN, and the Journal of American Medical Association benchmark. The correlations between user engagement metrics (likes, comments, shares, and favorites) and quality scores were also analyzed. In total, 176 videos were included. Most videos focused on treatment (TikTok and Bilibili: 31.6% and 36.1%, respectively) and prognosis (TikTok and Bilibili: 24.4% vs 17.3%, respectively), while pathogeny and clinical manifestations were insufficiently covered. The overall quality was modest: global quality score median 3.00 (interquartile range [IQR]: 2.00-4.00), modified DISCERN median 2.00 (IQR: 1.00-3.00), and Journal of American Medical Association median 2.00 (IQR: 2.00-3.00). TikTok videos demonstrated a significantly higher engagement than Bilibili videos (P < .05), whereas Bilibili videos were longer (P < .05). Videos uploaded by hematologists received the highest scores across all 3 tools (all P < .001) but showed relatively low user engagement. No correlation was found between engagement metrics and quality scores (P > .05). Short video platforms have become an important source of AML information; however, their overall content quality is limited. Videos created by hematologists are the most reliable; however, user engagement does not reflect information quality. Professional physicians should be encouraged to actively participate in science communication, and platform regulations and algorithm optimization should be strengthened to promote the dissemination of high-quality information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.